Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.493761
Title: Drug binding sites on Nat1.8 sodium channels
Author: Browne, Liam Edward
Awarding Body: University of Leeds
Current Institution: University of Leeds
Date of Award: 2008
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
The voltage-gated sodium channel, Nav 1.8, is known to play an important role in pain signalling. In this thesis, the functional properties and drug binding sites of wild type and mutant Nav 1.8 sodium channel currents were studied in mammalian sensory neuron-derived ND7/23 cells using whole-cell patch clamp. While the voltage-dependence of activation was similar for wild type human and rat Nay 1.8 channels, the voltage-dependence of steady-state inactivation was more hyperpolarised for hNav 1.8 compared to rNav 1.8. Furthermore, as a consequence of the different time course for inactivation between human and rat channels, inhibition during frequent stimulation was less pronounced for hNav 1.8 than for rNav 1.8. Thus, this would imply that the human channel is more inactivated at normal resting potentials, and can support higher firing frequencies than the rat channel. The action of tetracaine, ralfmamide, 227c89, Vl02862, and Nav1. 8-selective compound A-803467 on wild type hNav 1.8 and rNav 1.8 channels was studied. All compounds showed preferential block of inactivated channels rather than resting channels. Compound A-803467 showed greater affinity for inactivated hNav 1.8 channels than for inactivated rNav 1.8 channels. Unexpectedly, an increase in current was observed for V102862 and A-803467 during recovery from inactivation, likely due to "disinhibition" of resting block. For A-803467, rather than usedependent inhibition, this disinhibition increased the current during frequent stimulation, while for VI 02862 it led to the absence of inhibition during low frequency stimulation. Thus while both V 102862 and A-803467 are potent inhibitors ofNav 1.8, V102862, rather than A-803467 might be a more useful blocker where physiological firing frequencies are higher. Alanine mutations at residues 1381, N390, L14l0, V14l4, Il706, F1710 and Y1717 were made in the pore-lining S6 segments of the hN av 1. 8 channel, and at the corresponding positions in the rNav 1.8 channel. Many of the mutations caused shifts in voltage-dependence of activation and inactivation, and gave a faster time course of inactivation, indicating that the native residues at these positions are important for both activation and inactivation in Nav 1.8 sodium channels. The affinity of tetracaine for the resting and inactivated channels was reduced by hNav1.8 mutations 138lA, F1710A and Y1717A (only inactivated state affinity was measured for the latter), and by mutation F17l0A for A-803467. For mutation L1410A both compounds caused complete resting block at very low concentrations; this block was removed by further stimulation. While tetracaine did not show disinhibition for wild type channels during recovery from inactivation, it was seen particularly for mutants L1410 and F1710A. All mutations increased the extent of disinhibition of A-803467. These results suggest that the Nav 1.8-selective compound A-803467 acts within the pore S6 segments with a differing but partially overlapping site to that of the local anaesthetic tetracaine.
Supervisor: Wray, D. Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.493761  DOI: Not available
Share: